Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Rimegepant for the Prevention of Episodic Migraine in Adults with Prior Inadequate Response to Oral Preventatives: Results from a 12-week Open-label Extension Phase of a Randomized, Placebo-controlled Trial

Touch-Screen Automatisms With Stereotyped Postictal Texting Behavior In A Case Of Drug And Surgical Refractory Epilepsy